Report cover image

Analgesics in Uzbekistan

Published Oct 15, 2025
Length 22 Pages
SKU # EP20490788

Description

In 2025, the rate of growth in retail current value sales of analgesics in Uzbekistan slowed but remained in double digits, driven largely by inflation. Growth in demand peaked during the post-COVID period, a time marked by heightened public attention to health and a surge in demand for OTC pain relief. Although this post-pandemic momentum continues to support market performance, economic constraints and affordability concerns have weighed on growth.

Euromonitor International's Analgesics in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

22 Pages
Analgesics in Uzbekistan
Euromonitor International
October 2025
List Of Contents And Tables
ANALGESICS IN UZBEKISTAN
KEY DATA FINDINGS
2025 DEVELOPMENTS
Growth in retail current value sales eases, as post-pandemic demand ebbs
Radiks NPP benefits from increased regulatory scrutiny of Indian brands
Pharmacies remain the sole distribution channel
PROSPECTS AND OPPORTUNITIES
Persistent supply-side imbalance will continue to limit growth
E-commerce will grow in importance
Deregulation will boost price competition
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2020-2025
Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN UZBEKISTAN
EXECUTIVE SUMMARY
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 8 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2020-2025
Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 13 Penetration of Private Label by Category: % Value 2020-2025
Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.